Abstract
The article has been withdrawn at the request of the authors of the journal Letters in Drug Design & Discovery.
Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php
Bentham Science Disclaimer:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Letters in Drug Design & Discovery
Title:Withdrawal Notice: Computational Design of a Novel Candidate Multi- Epitope Vaccine to Boost Immune Responses against SARS-COV-2
Volume: 19
Author(s): Shiva Mohammadi, Soudabe Kavusi Pour, Mahdi Barazesh*, Yadollah Bahrami*Sajad Jalili
Affiliation:
- School of Paramedical, Gerash University of Medical Sciences, Gerash,Iran
- Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah6714415185,Iran
Abstract: The article has been withdrawn at the request of the authors of the journal Letters in Drug Design & Discovery.
Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php
Bentham Science Disclaimer:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.
Export Options
About this article
Cite this article as:
Mohammadi Shiva , Pour Kavusi Soudabe, Barazesh Mahdi *, Bahrami Yadollah*, Jalili Sajad, Withdrawal Notice: Computational Design of a Novel Candidate Multi- Epitope Vaccine to Boost Immune Responses against SARS-COV-2, Letters in Drug Design & Discovery 2022; 19 () . https://dx.doi.org/10.2174/1570180818666211011094822
DOI https://dx.doi.org/10.2174/1570180818666211011094822 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress in the Discovery of BACE Inhibitors
Current Pharmaceutical Design Novel Strategies for the Treatment of Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Drug-Like Property Concepts in Pharmaceutical Design
Current Pharmaceutical Design Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects
Current Protein & Peptide Science Accounting Receptor’s Dynamic Behavior into Structure-based Design
Combinatorial Chemistry & High Throughput Screening A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Current Pharmaceutical Design Construction, Expression, Purification and Biotin Labeling of a Single Recombinant Multi-Epitope Antigen for Double-Antigen Sandwich ELISA to Detect Hepatitis C Virus Antibody
Protein & Peptide Letters Identification of Novel Scaffolds for IκB Kinase Beta Inhibitor via a High Throughput Screening TR-FRET Assay
Combinatorial Chemistry & High Throughput Screening Predictive QSAR Modeling Workflow, Model Applicability Domains, and Virtual Screening
Current Pharmaceutical Design Herbal and Ayurvedic Plants as Remedial Approach for Viral Diseases with Focus on COVID-19: A Narrative Review
Current Traditional Medicine A Novel Class of Emerging Anticancer Compounds: Oxyprenylated Secondary Metabolites from Plants and Fungi
Current Medicinal Chemistry Identification of Potential Inhibitors for Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) Angiotensin-converting Enzyme 2 and the Main Protease from Anatolian Traditional Plants
Letters in Drug Design & Discovery Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogenactivated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases
Recent Patents on Anti-Cancer Drug Discovery Liver Injury in COVID-19: A Direct Hit or Collateral Damage?
Infectious Disorders - Drug Targets Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems
Current Medical Imaging Recent Progress in Structure Activity Relationship and Mechanistic Studies of Taxol Analogues
Mini-Reviews in Medicinal Chemistry Mesoscopic Solar Cell Sensitization: From Dye to Organometal Perovskite
Current Nanoscience Ribonucleases: From Prototypes to Therapeutic Targets? (General Articles)
Current Medicinal Chemistry Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled Receptor
Current Medicinal Chemistry